HTIC is conducting the 4th International Fellowship on Health Technology Assessment (HTA) from 28th July to 2nd August, 2014. We would like to invite participation from faculty and students of your organisation for this fellowship program.
For many who suffer from chronic migraines, nothing can reliably prevent or dull the debilitating headaches that may strike as often as every other day.
A biopharmaceutical company in Bothell, Washington, may have a solution. It hopes that a monthly injection of an antibody that blocks a well-known migraine-triggering protein will prevent these headaches.
The company, called Alder Biopharmaceuticals, is testing the efficacy of the drug in a clinical study of 160 patients, each of whom has between four and 14 migraines per month; Alder expects the results of the study to be in this fall.
According to the World Health Organization, cardiovascular diseases (CVD) are the number one cause of death worldwide. Of these deaths, 82% take place in low- and middle-income countries. Given their computing power and pervasiveness, is it possible for mobile phones to aid in delivery of quality health care, particularly to rural populations distant from physicians with the expertise needed to diagnose CVD?
Advances in mobile phone technology have resulted in global availability of portable computing devices capable of performing many of the functions traditionally requiring desktop and larger computers. In addition to their technological features, mobile phones have a large cultural impact. They are user-friendly and are among the most efficient and most widely used means of communication. Currently there is about one cell phone for every two humans in the world.